UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000044456
Receipt No. R000049508
Scientific Title Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients
Date of disclosure of the study information 2021/06/09
Last modified on 2021/06/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients
Acronym Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients
Scientific Title Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients
Scientific Title:Acronym Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients
Region
Japan

Condition
Condition COVID-19 hospitalized patients
Classification by specialty
Medicine in general Endocrinology and Metabolism Infectious disease
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We investigate the feasibility of remote intermitted-scanned glucose monitoring in hospitalized, quarantined covid-19 patients
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Profiles of sensor glucose level by intermitted-scanned continuous glucose monitoring
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria COVID-19 patients aged 20 years or older who were admitted to our hospital, (1) patients who have been diagnosed with diabetes before admission, and (2) patients who receive steroid treatment regardless of the presence or absence of diabetes.
Key exclusion criteria 1. Patients who did not agree to participate in this study
2. Patients scheduled to undergo surgery and MRI
3. Patients using implantable medical devices such as pacemakers
4. Patients with systemic edema
5. Patients with a hyperglycemic emergency (diabetic ketoacidosis, hyperglycemic hyperosmolar syndrome)
6. Patients using acetaminophen of 4000mg or more per day
7. Patients who have difficulty wearing the continuous glucose monitoring sensor due to skin problems
8. Pregnant patients
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Akinori
Middle name
Last name Hayashi
Organization Kitasato University School of Medicine
Division name Department of Laboratory Medicine
Zip code 252-0374
Address 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374 Japan
TEL 042-778-8111
Email ahayashi@kitasato-u.ac.jp

Public contact
Name of contact person
1st name Akinori
Middle name
Last name Hayashi
Organization Kitasato University School of Medicine
Division name Department of Laboratory Medicine
Zip code 252-0374
Address 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374 Japan
TEL 042-778-8111
Homepage URL
Email ahayashi@kitasato-u.ac.jp

Sponsor
Institute Kitasato University School of Medicine
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Research Ethics Committee of the Kitasato University School of Medicine
Address 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374 Japan
Tel 0427788111
Email rinrib@med.kitasato-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 06 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 06 Month 07 Day
Date of IRB
2021 Year 06 Month 07 Day
Anticipated trial start date
2021 Year 06 Month 07 Day
Last follow-up date
2023 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Retrospective and prospective observational study

Management information
Registered date
2021 Year 06 Month 07 Day
Last modified on
2021 Year 06 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049508

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.